United Kingdom National External Quality Assessment Service for Microbiology [Established 1971]

Similar documents
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Appendix F: Test-Curriculum Matching Analysis

BioPlex 2200 Infectious Disease Panels

Smokefree Policies in Europe: Are we there yet?

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Monthly measles and rubella monitoring report

Main developments in past 24 hours

Global EHS Resource Center

LEBANON. WCPT COUNTRY PROFILE December 2018

DENMARK. WCPT COUNTRY PROFILE December 2018

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

GERMANY. WCPT COUNTRY PROFILE December 2018

Tobacco: World Markets and Trade

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Third Party Controls for Your Dade Behring Systems

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Overview of drug-induced deaths in Europe - What does the data tell us?

The Identification of Food Safety Priorities using the Delphi Technique

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Microbiology EQA Product Portfolio

Cross Border Genetic Testing for Rare Diseases

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Available Hepatitis Information: how can this be used to convince decision makers and potential funders

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Engagement in language assessment / Regions of Europe

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Where we stand in EFORT

European Collaboration on Dementia. Luxembourg, 13 December 2006

Outcome of proficiency test on EIA serology

Critical immunity thresholds for measles elimination

EUVAC.NET A surveillance network for vaccine-preventable diseases

Weekly Influenza Surveillance Report. Week 11

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

VIRUS VACCINES & CANCER a story with two chapters

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Summary. Primary care data. Week 49/2014. Season

Alcohol-related harm in Europe and the WHO policy response

Terms and Conditions. VISA Global Customer Assistance Services

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

World Connections Committee (WCC) Report

Louisville '19 Attachment #69

Bio-Rad Laboratories. The Best Protection Whoever You Are. Congenital and Pediatric Disease Testing

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

Access to treatment and disease burden

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

European Community Pharmacy: a reference in Public Health

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Q1 What age are you?

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

CND UNGASS FOLLOW UP

The Test-Curriculum Matching Analysis: Science

Measles and rubella monitoring January 2015

Estimating the parasitaemia of Plasmodium falciparum: experience from a national EQA scheme

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

ORBE Summary of Benefits

Monitoraggio delle epatiti virali in Europa

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

THE CARE WE PROMISE FACTS AND FIGURES 2017

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

European Status report on Alcohol and Health

Angelos Hatzakis. 10th Paris Hepatology Conference

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

The cancer burden in the European Union and the European Region: the current situation and a way forward

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Recommended composition of influenza virus vaccines for use in the influenza season

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Common EQA Mistakes - A provider Perspective. Experience from East African Regional External Quality Assessment Scheme (EA-REQAS)

NobelProcera Implant Bar Overdenture EXPERIENCE THE NEW WORLD OF CAD/CAM DENTISTRY

Weekly influenza surveillance overview

HPV Vaccines: Background and Current Status

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

GLOBAL FMD SITUATION DURING 2001/2002

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

European status report on alcohol and health Leadership, awareness and commitment

Transcription:

United Kingdom National External Quality Assessment Service for Microbiology [Established 97]

UK NEQAS covers Andrology Chemistry Genetics Haematology Histopathology Immunology Leucocyte Immunophenotyping Microbiology male fertility investigations blood chemical components genetic analysis blood cellular components and blood grouping structure and function of body tissues components of the immune system in blood immune monitoring of white blood cells infectious agents & antibiotics

Participation Statistics for 2007 to 2008 32 schemes 25 distributions 424 different specimens 5,032 specimens sent 655 registered laboratories 45 countries 9553 participating laboratories ie. labs registered for 5.8 schemes on average

PARTICIPATION IN UK NEQAS FOR MICROBIOLOGY 2008 Austria 48 Greenland Morocco Switzerland 74 Bahrain Hong Kong 3 Netherlands 32 Tanzania Belgium 34 Iceland 3 Norway 7 Turkey 65 Croatia 9 Ireland 62 Poland UAE 5 Cyprus 0 Israel 35 Portugal 227 Uganda 2 Denmark 53 Italy 267 Qatar UK 432 Finland 34 Kenya 2 Romania 4 USA 2 France 3 Kuwait 5 Saudi Arabia Vietnam Gambia Lao People s Democratic Republic Sierra Leone Zimbabwe Germany 8 Macau Slovenia 9 Gibralta Malawi 2 South Africa 34 Greece 50 Malta Sweden 8

Bacteriology AAFB microscopy Antimicrobial Susceptibility Community Medicine General bacteriology & Antimicrobial Susceptibility General bacteriology (ID only) Mycobacterium culture Syphilis serology Molecular HBV DNA quantification Hepatitis C RNA detection HIV RNA quantification Molecular detection of C. trachomatis Molecular detection of viruses in CSF CMV DNA quantification Molecular detection of mycobacteria Mycology Mycology culture Clinical Microbiology EQA Schemes 5 Antifungal and 6 October susceptibility 2008 Biognostica - Portugal Parasitology Blood parasitology Faecal parasitology Parasite serology Toxoplasma serology Toxoplasma IgM serology Virology Anti-HBs detection Blood Borne Virus Diagnostic serology (exanthem screen) Diagnostic serology (hepatitis screen) Hepatitis B serology Hepatitis C serology HIV serology Immunity screen Rubella IgG serology Virus identification

Size and Complexity No. distributions per year No. specimens per annum No. UK participants No. non-uk participants Total no. participants Bacteriology Virus isolation 2 2 36 8 294 56 475 55 769

Why choose UK NEQAS? Comprehensive coverage clinical microbiology High frequency of distributions International comparability Country specific performance Operate to stringent, defined quality standards Fast turnaround times Fully accredited schemes

Accreditation Standards Standards based on: ISO 900 Quality management systems - requirements ISO/IEC 7025:999 General requirements for the competence of testing and calibration laboratories ISO Guide 43 parts and 2:997 Proficiency testing by interlaboratory comparisons: () Development and operation of proficiency testing Schemes (2) Selection and use of proficiency testing Schemes by laboratory accreditation bodies ILAC G3:2000 Guidelines for the requirements for the competence of providers of proficiency testing Schemes Under development: ISO 7043

Report formats Qualitative (Serology schemes: HIV, HBV, HCV, Toxoplasma, Immunity screen, Diagnostic serology, Syphilis) Quantitative (Anti-HBs, Rubella, HCV RNA Detection, HIV RNA quantification, HBV DNA quantification) Named pathogen (General Bacteriology, Virus Identification, Faecal and Blood Parasitology, Mycology, Mycobacterium Culture, Molecular detection of Viruses in CSF) Antimicrobial and Antifungal Susceptibility

Serology scheme results are presented so that laboratories can compare results by methods

New schemes Introduced 2007 CMV DNA quantification Antifungal susceptibility Molecular detection of mycobacteria In development Measles/Mumps serology MRSA screening HPV DNA detection